GiT Updates and More
Open in Telegram
Gi doctor with interests in endoscopy, gut health, liver & medicine in general.
Show more5 318
Subscribers
+124 hours
+277 days
+9530 days
Posts Archive
5 318
A novel approach to achieve deep remission in dupilumab-refractory EoE:
Dupilumab plus exclusive palatable elemental diet for two weeks led to sustained symptomatic and normalization of esophageal distensibility
#ACG2025
5 318
Balancing Act: Managing Active Bleeding and Risk of Thrombosis in the Hospital.
#ACG2025
PDF 👇
5 318
Acute Severe Ulcerative Colitis Optimizing Inpatient Management for Improved Outcomes.
#ACG2025
PDF 👇
5 318
Managing Cirrhosis and Its Complications: Inpatient Strategies for Optimal Care.
#ACG2025
PDF 👇
5 318
Diverticular Disease: Unpacking the Pockets of Mystery and Navigating Effective Management.
#ACG2025
PDF 👇
5 318
In patients with gastroparesis undergoing G-POEM, having repeated past botox injections is associated with longer procedural times. Probably due to fibrosis.
#ACG2025
5 318
G-POEM is gaining popularity compared to gastric electrical stimulation for gastroparesis, in particular in younger patients.
#ACG2025
5 318
👉 Patients with FD/ gastroparesis carry a substantially greater and earlier burden compared to those with IBS.
👉 IBS has been known to be associated with psychological symptoms.
5 318
⚠️PSC in 2025: no approved drugs, heterogeneous course & shaky endpoints.
Hepatology review
5 318
Review: Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?
PDF 👇
AASLD Hepatology 82(4):p 927-948, October 2025.
5 318
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update.
PDF 👇
Journal of Hepatology 26 October 2025
5 318
Besting Barrett's: Advances in the Diagnosis and Treatment of Barrett's Esophagus .
#ACG2025
PDF👇
